ORM-5029

CAT:
931-T210135-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
ORM-5029 - image 1

ORM-5029

  • Target :

    Antibody-Drug Conjugates (ADCs)
  • Related Pathways :

    Antibody-drug Conjugate/ADC Related
  • Bioactivity :

    ORM-5029 is the first antibody-drug conjugate (ADC) targeting the human epidermal growth factor receptor 2 (HER2), combining the highly potent GSPT1 degrader SMol006 with Pertuzumab. It is applicable in cancer research.
  • Shipping Conditions :

    Cool pack
  • Storage Temperature :

    -20°C

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide